141 related articles for article (PubMed ID: 37209493)
1. Expanding the phenotype of DNMT3A as a cause a congenital myopathy with rhabdomyolysis.
Ghaoui R; Ha TT; Kerkhof J; McConkey H; Gao S; Babic M; King R; Ravenscroft G; Koszyca B; Otto S; Laing NG; Scott H; Sadikovic B; Kassahn KS
Neuromuscul Disord; 2023 Jun; 33(6):484-489. PubMed ID: 37209493
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukaemia in a case with Tatton-Brown-Rahman syndrome: the peculiar
Hollink IHIM; van den Ouweland AMW; Beverloo HB; Arentsen-Peters STCJM; Zwaan CM; Wagner A
J Med Genet; 2017 Dec; 54(12):805-808. PubMed ID: 28432085
[TBL] [Abstract][Full Text] [Related]
3. Tatton-Brown-Rahman syndrome: Novel pathogenic variants and new neuroimaging findings.
Jiménez de la Peña M; Rincón-Pérez I; López-Martín S; Albert J; Martín Fernández-Mayoralas D; Fernández-Perrone AL; Jiménez de Domingo A; Tirado P; Calleja-Pérez B; Porta J; Álvarez S; Fernández-Jaén A
Am J Med Genet A; 2024 Feb; 194(2):211-217. PubMed ID: 37795572
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia-associated DNMT3A p.Arg882His mutation in a patient with Tatton-Brown-Rahman overgrowth syndrome as a constitutional mutation.
Kosaki R; Terashima H; Kubota M; Kosaki K
Am J Med Genet A; 2017 Jan; 173(1):250-253. PubMed ID: 27991732
[TBL] [Abstract][Full Text] [Related]
5. Aortic root dilatation and dilated cardiomyopathy in an adult with Tatton-Brown-Rahman syndrome.
Cecchi AC; Haidar A; Marin I; Kwartler CS; Prakash SK; Milewicz DM
Am J Med Genet A; 2022 Feb; 188(2):628-634. PubMed ID: 34644003
[TBL] [Abstract][Full Text] [Related]
6. Dnmt3a deficiency in the skin causes focal, canonical DNA hypomethylation and a cellular proliferation phenotype.
Chen DY; Ferguson IM; Braun KA; Sutton LA; Helton NM; Ramakrishnan SM; Smith AM; Miller CA; Ley TJ
Proc Natl Acad Sci U S A; 2021 Apr; 118(16):. PubMed ID: 33846253
[TBL] [Abstract][Full Text] [Related]
7. Further delineation of neuropsychiatric findings in Tatton-Brown-Rahman syndrome due to disease-causing variants in DNMT3A: seven new patients.
Tenorio J; Alarcón P; Arias P; Dapía I; García-Miñaur S; Palomares Bralo M; Campistol J; Climent S; Valenzuela I; Ramos S; Monseny AM; Grondona FL; Botet J; Serrano M; Solís M; Santos-Simarro F; Álvarez S; Teixidó-Tura G; Fernández Jaén A; Gordo G; Bardón Rivera MB; Nevado J; Hernández A; Cigudosa JC; Ruiz-Pérez VL; Tizzano EF; ; Lapunzina P
Eur J Hum Genet; 2020 Apr; 28(4):469-479. PubMed ID: 31685998
[TBL] [Abstract][Full Text] [Related]
8. The spectrum of DNMT3A variants in Tatton-Brown-Rahman syndrome overlaps with that in hematologic malignancies.
Shen W; Heeley JM; Carlston CM; Acuna-Hidalgo R; Nillesen WM; Dent KM; Douglas GV; Levine KL; Bayrak-Toydemir P; Marcelis CL; Shinawi M; Carey JC
Am J Med Genet A; 2017 Nov; 173(11):3022-3028. PubMed ID: 28941052
[TBL] [Abstract][Full Text] [Related]
9. Growth disrupting mutations in epigenetic regulatory molecules are associated with abnormalities of epigenetic aging.
Jeffries AR; Maroofian R; Salter CG; Chioza BA; Cross HE; Patton MA; Dempster E; Temple IK; Mackay DJG; Rezwan FI; Aksglaede L; Baralle D; Dabir T; Hunter MF; Kamath A; Kumar A; Newbury-Ecob R; Selicorni A; Springer A; Van Maldergem L; Varghese V; Yachelevich N; Tatton-Brown K; Mill J; Crosby AH; Baple EL
Genome Res; 2019 Jul; 29(7):1057-1066. PubMed ID: 31160375
[TBL] [Abstract][Full Text] [Related]
10. Perturbed hematopoiesis in individuals with germline DNMT3A overgrowth Tatton-Brown-Rahman syndrome.
Tovy A; Rosas C; Gaikwad AS; Medrano G; Zhang L; Reyes JM; Huang YH; Arakawa T; Kurtz K; Conneely SE; Guzman AG; Aguilar R; Gao A; Chen CW; Kim JJ; Carter MT; Lasa-Aranzasti A; Valenzuela I; Van Maldergem L; Brunetti L; Hicks MJ; Marcogliese AN; Goodell MA; Rau RE
Haematologica; 2022 Apr; 107(4):887-898. PubMed ID: 34092059
[TBL] [Abstract][Full Text] [Related]
11. Tatton-Brown-Rahman syndrome due to 2p23 microdeletion.
Okamoto N; Toribe Y; Shimojima K; Yamamoto T
Am J Med Genet A; 2016 May; 170A(5):1339-42. PubMed ID: 26866722
[TBL] [Abstract][Full Text] [Related]
12. Tatton-Brown-Rahman syndrome: Six individuals with novel features.
Balci TB; Strong A; Kalish JM; Zackai E; Maris JM; Reilly A; Surrey LF; Wertheim GB; Marcadier JL; Graham GE; Carter MT
Am J Med Genet A; 2020 Apr; 182(4):673-680. PubMed ID: 31961069
[TBL] [Abstract][Full Text] [Related]
13. The first case report of medulloblastoma associated with Tatton-Brown-Rahman syndrome.
Sweeney KJ; Mottolese C; Belot A; Szathmari A; Frappaz D; Lesca G; Putoux A; Di Rocco F
Am J Med Genet A; 2019 Jul; 179(7):1357-1361. PubMed ID: 31066180
[TBL] [Abstract][Full Text] [Related]
14. [Tatton-Brown-Rahman Syndrome: Case report and DNMT3A variant not previously reported associated to the syndrome].
Martin M F; Díaz S C; Mira O M
Andes Pediatr; 2022 Aug; 93(4):561-567. PubMed ID: 37906855
[TBL] [Abstract][Full Text] [Related]
15. Co-occurrence of a maternally inherited
Polonis K; Blackburn PR; Urrutia RA; Lomberk GA; Kruisselbrink T; Cousin MA; Boczek NJ; Hoppman NL; Babovic-Vuksanovic D; Klee EW; Pichurin PN
Cold Spring Harb Mol Case Stud; 2018 Aug; 4(4):. PubMed ID: 29802153
[TBL] [Abstract][Full Text] [Related]
16. [Tatton-Brown-Rahman syndrome associated with the DNMT3A gene: a case report and literature review].
Chen M; Li ST; Cai Y; Xiao X; Shi CC; Hao H
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Oct; 22(10):1114-1118. PubMed ID: 33059810
[TBL] [Abstract][Full Text] [Related]
17. Methylation signatures in clinically variable syndromic disorders: a familial DNMT3A variant in two adults with Tatton-Brown-Rahman syndrome.
Kumps C; D'haenens E; Kerkhof J; McConkey H; Alders M; Sadikovic B; Vanakker OM
Eur J Hum Genet; 2023 Dec; 31(12):1350-1354. PubMed ID: 37736838
[No Abstract] [Full Text] [Related]
18. Acromegaly in the setting of Tatton-Brown-Rahman Syndrome.
Hage C; Sabini E; Alsharhan H; Fahrner JA; Beckers A; Daly A; Salvatori R
Pituitary; 2020 Apr; 23(2):167-170. PubMed ID: 31858400
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the DNA methyltransferase gene DNMT3A cause an overgrowth syndrome with intellectual disability.
Tatton-Brown K; Seal S; Ruark E; Harmer J; Ramsay E; Del Vecchio Duarte S; Zachariou A; Hanks S; O'Brien E; Aksglaede L; Baralle D; Dabir T; Gener B; Goudie D; Homfray T; Kumar A; Pilz DT; Selicorni A; Temple IK; Van Maldergem L; Yachelevich N; ; van Montfort R; Rahman N
Nat Genet; 2014 Apr; 46(4):385-8. PubMed ID: 24614070
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
